We are live on
!
Find out more
DHFB
Dixon Hubard Feinour & Brown Portfolio holdings
AUM
$842M
1-Year Est. Return
2.74%
This Fund
S&P 500
This Quarter
Est. Return
+9.49%
1 Year Est. Return
-2.74%
3 Year Est. Return
+59.78%
5 Year Est. Return
+118.87%
10 Year Est. Return
–
AUM
$390M
AUM Growth
$0
(0%)
Cap. Flow
-$658K
Cap. Flow
% of AUM
-0.17%
Top 10 Holdings %
Top 10 Hldgs %
36.69%
Holding
181
New
–
Increased
–
Reduced
3
Closed
–
Top Buys
No buys this quarter
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$257K |
| 2 |
NetEase
NTES
|
+$215K |
| 3 |
NextEra Energy
NEE
|
+$186K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 24.4% |
| 2 | Technology | 24.34% |
| 3 | Consumer Discretionary | 11.23% |
| 4 | Communication Services | 8.9% |
| 5 | Consumer Staples | 7.76% |
Similar funds
BDWM
MCM
TFM
MWM
CP
BWM
FPS
IC
Dixon Hubard Feinour & Brown's Q4 2020 Portfolio in Review
As of Q4 2020, Dixon Hubard Feinour & Brown held 181 positions worth $390M, unchanged from the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Trading was light in Q4 2020: portfolio turnover was 0%. Dixon Hubard Feinour & Brown opened no new positions and made no exits, leaving the 181-position portfolio largely intact.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, unchanged from a quarter earlier, followed by Technology and Consumer Discretionary.
- Dixon Hubard Feinour & Brown's biggest Q4 2020 reduction was Pfizer, cutting an estimated $257K.
- Dixon Hubard Feinour & Brown's ten largest holdings make up 37% of its $390M portfolio in Q4 2020.
- Dixon Hubard Feinour & Brown opened 0 new positions and closed 0 in Q4 2020.
- Dixon Hubard Feinour & Brown's portfolio value was unchanged quarter-over-quarter at $390M.
Based on Dixon Hubard Feinour & Brown's 13F filing for Q4 2020, filed 12 Feb 2021.